Artefill for the Treatment of HIV-associated Facial Lipoatrophy

NCT02009462 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

HIV-facial Lipoatrophy

Interventions

DRUG: Artefill dermal filler

Sponsor

Gerald Pierone, Jr. M.D.

Collaborators

[object Object]